ATG7 and prostate carcinoma: However, we can't ascertain with confidence that targeting ATG7 is an off-target effect, because miR-96 level was inversely correlated with the protein levels of ATG7 (Fig. 7B, 7C) in prostate cancer tissues, which indicated miR-96 might target ATG7 in prostate cancer tissues.